Immobilisation of GM-CSF onto particulate vaccine carrier systems

Author： Mandal B.   Kempf M.   Merkle H.P.   Walter E.  

Publisher： Elsevier

ISSN： 0378-5173

Source： International Journal of Pharmaceutics, Vol.269, Iss.1, 2004-01, pp. : 259-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

GM-CSF beneficial in idiopathic alveolar proteinosis

By  

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

GM-CSF may be a novel strategy for Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

G-CSF vs GM-CSF: cost of adverse events makes all the difference

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Structure-based Design of Mimetics for Granulocyte-macrophage Colony Stimulating Factor (GM-CSF)

By  

Current Pharmaceutical Design, Vol. 8, Iss. 24, 2002-11 ,pp. : 2185-2199

Bentham Science Publishers

Access to resources Recommend Favorite

Salmeterol Inhibits the Allergen-induced Mononuclear Cell Proliferation and Downregulates GM-CSF Release and HLA-DR Expression by Monocytes

By Oddera S.   Silvestri M.   Scarso L.   Testi R.   Rossi G.A.  

Pulmonary Pharmacology & Therapeutics, Vol. 10, Iss. 1, 1997-02 ,pp. : 43-49

Academic Press

Access to resources Recommend Favorite